Details of issuance or disposal
Monthly exercise status of Series 1 Stock Acquisition Rights issued through a third-party allotment, with a fixed exercise price
Shares issued during the relevant month: 43,500 new shares. Treasury shares transferred: not stated (shown as “—,” not 0 shares)
43,500 new shares issued during the relevant month, compared with 1,812,233 shares issued and outstanding. The overall dilution rate is not stated
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of Series 1 Stock Acquisition Rights issued through a third-party allotment, with a fixed exercise price |
| Number of shares to be issued or disposed of | Shares issued during the relevant month: 43,500 new shares. Treasury shares transferred: not stated (shown as “—,” not 0 shares) |
| Payment date | 15 December 2025 (date of issue of the Stock Acquisition Rights) |
| Dilution Rate | 43,500 new shares issued during the relevant month, compared with 1,812,233 shares issued and outstanding. The overall dilution rate is not stated |
| Total number of issued shares | At the end of the month preceding the relevant month: 1,812,233 shares → Not disclosed |
| Exercise price | ¥2,295 per share. The exercise price is fixed and will not be revised |
| Number of Stock Acquisition Rights | Total issued: 21,000 units. Unexercised at the end of the month preceding the relevant month: 17,550 units; unexercised at month-end: 17,115 units |
| Most recent equity financing | 15 December 2025: Issue of Series 1 Stock Acquisition Rights (total issued: 21,000 units) |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Based on the information announced on 20 November 2025, the Company discloses the monthly exercise status of these Stock Acquisition Rights, which have a fixed exercise price, to provide information to shareholders and investors.